期刊
ACTA TROPICA
卷 165, 期 -, 页码 66-75出版社
ELSEVIER
DOI: 10.1016/j.actatropica.2016.02.012
关键词
Cbte d'Ivoire; Human; Livestock; Brucellosis; Q Fever; Rift Valley Fever
资金
- National Center of Competence in Research North-South (NCCR North-South)
- City of Basel (Stipendienkommission fur Nachwuchskrafte aus Entwicklungslandern')
- Freiwillige Akademische Gesellschaft
Northern Cote d'Ivoire is the main livestock breeding zone and has the highest livestock cross-border movements in Cote d'Ivoire. The aim of this study was to provide updated epidemiological data on three neglected zoonotic diseases, namely brucellosis, Q Fever and Rift Valley Fever (RVF). We conducted three-stage cross-sectional cluster surveys in livestock and humans between 2012 and 2014 in a random selection of 63 villages and a sample of 633 cattle, 622 small ruminants and 88 people. We administered questionnaires to capture risk factors and performed serological tests including the Rose Bengal Plate Test (RBPT), Brucella spp. indirect and competitive ELISAs, Coxiella burnetii indirect ELISA and RVF competitive ELISA. The human seroprevalence for Brucella spp. was 5.3%. RBPT-positive small ruminants tested negative by the indirect ELISA. The seroprevalence of Brucella spp. in cattle adjusted for clustering was 4.6%. Cattle aged 5-8 years had higher odds of seropositivity (OR = 3.5) than those aged <= 4 years. The seropositivity in cattle was associated with having joint hygromas (OR = 9), sharing the pastures with small ruminants (OR = 5.8) and contact with pastoralist herds (OR = 11.3). The seroprevalence of Q Fever was 13.9% in cattle, 9.4% in sheep and 12.4% in goats. The seroprevalence of RVF was 3.9% in cattle, 2.4% in sheep and 0% in goats. Seropositive ewes had greater odds (OR = 4.7) of abortion than seronegative ones. In cattle, a shorter distance between the night pens and nearest permanent water bodies was a protective factor (OR = 0.1). The study showed that the exposure to the three zoonoses is rather low in northern Cote d'Ivoire. Within a One Health approach, cost-benefit and cost-effectiveness of control measures should be assessed for an integrated control. (C) 2016 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据